| Primary |
| Glaucoma |
48.0% |
| Ocular Hypertension |
7.2% |
| Eye Operation |
5.6% |
| Intraocular Pressure Increased |
4.8% |
| Open Angle Glaucoma |
4.8% |
| Eye Inflammation |
4.0% |
| Hypertension |
4.0% |
| Developmental Glaucoma |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Dry Eye |
2.4% |
| Keratoconjunctivitis Sicca |
2.4% |
| Anterior Chamber Disorder |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Gout |
1.6% |
| Pigmentary Glaucoma |
1.6% |
| Cardiac Assistance Device User |
0.8% |
| Corneal Dystrophy |
0.8% |
| Depression |
0.8% |
| Macular Degeneration |
0.8% |
| Metastatic Renal Cell Carcinoma |
0.8% |
|
| Depressed Level Of Consciousness |
8.9% |
| Intraocular Pressure Increased |
8.9% |
| Vision Blurred |
8.9% |
| Eye Pruritus |
6.7% |
| Ocular Hyperaemia |
6.7% |
| Pseudophaeochromocytoma |
6.7% |
| Visual Impairment |
6.7% |
| Cough |
4.4% |
| Eye Swelling |
4.4% |
| Foreign Body Sensation In Eyes |
4.4% |
| Hypersensitivity |
4.4% |
| Medication Residue |
4.4% |
| Pruritus |
4.4% |
| Somnolence |
4.4% |
| Unresponsive To Stimuli |
4.4% |
| Anal Discomfort |
2.2% |
| Basal Cell Carcinoma |
2.2% |
| Cardio-respiratory Distress |
2.2% |
| Chest Pain |
2.2% |
| Conjunctival Haemorrhage |
2.2% |
|
| Secondary |
| Glaucoma |
40.2% |
| Cataract Operation |
12.1% |
| Intraocular Pressure Increased |
8.7% |
| Open Angle Glaucoma |
6.8% |
| Ocular Hypertension |
5.7% |
| Intraocular Lens Implant |
4.2% |
| Anaemia |
3.0% |
| Atrial Fibrillation |
3.0% |
| Constipation |
3.0% |
| Drug Use For Unknown Indication |
2.7% |
| Endophthalmitis |
2.7% |
| Eye Inflammation |
2.3% |
| Eye Operation |
1.1% |
| Migraine |
1.1% |
| Blood Cholesterol Increased |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Sjogren's Syndrome |
0.8% |
| Corneal Dystrophy |
0.4% |
| Coronary Artery Disease |
0.4% |
| Diabetes Mellitus |
0.4% |
|
| Vitreous Haemorrhage |
16.9% |
| Intraocular Pressure Increased |
12.3% |
| Toxic Anterior Segment Syndrome |
10.8% |
| Nephropathy Toxic |
6.2% |
| Ocular Hyperaemia |
6.2% |
| Renal Impairment |
6.2% |
| Visual Field Defect |
6.2% |
| Drug Ineffective |
4.6% |
| Weight Decreased |
4.6% |
| Conjunctivitis Allergic |
3.1% |
| Drug Interaction |
3.1% |
| Hypersensitivity |
3.1% |
| Ocular Hypertension |
3.1% |
| Polyp |
3.1% |
| Post Procedural Complication |
3.1% |
| Cataract Operation Complication |
1.5% |
| Cerebrovascular Accident |
1.5% |
| Cough |
1.5% |
| Eye Inflammation |
1.5% |
| Eye Irritation |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.0% |
| Drug Use For Unknown Indication |
16.6% |
| Glaucoma |
14.3% |
| Hypertension |
6.2% |
| Pain |
4.1% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Depression |
2.9% |
| Atrial Fibrillation |
2.7% |
| Intraocular Pressure Increased |
2.5% |
| Prophylaxis |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Cardiac Failure Chronic |
2.2% |
| Diabetes Mellitus |
1.9% |
| Osteoporosis |
1.9% |
| Non-small Cell Lung Cancer |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Anxiety |
1.4% |
| Multiple Myeloma |
1.4% |
| Open Angle Glaucoma |
1.4% |
| Cardiac Failure Acute |
1.3% |
|
| Myositis |
9.8% |
| Wrist Fracture |
8.1% |
| Rash |
7.3% |
| Visual Acuity Reduced |
7.3% |
| Atrial Fibrillation |
5.7% |
| Fatigue |
5.7% |
| Pneumonia |
5.7% |
| Skin Exfoliation |
5.7% |
| Ocular Hyperaemia |
4.9% |
| Stevens-johnson Syndrome |
4.9% |
| Gastrointestinal Haemorrhage |
4.1% |
| Pruritus |
4.1% |
| Vision Blurred |
4.1% |
| Aggression |
3.3% |
| Blood Glucose Increased |
3.3% |
| Death |
3.3% |
| Eye Disorder |
3.3% |
| Intraocular Pressure Increased |
3.3% |
| Sick Sinus Syndrome |
3.3% |
| Suicidal Ideation |
3.3% |
|
| Interacting |
| Atrial Fibrillation |
50.0% |
| Atrial Flutter |
50.0% |
|
|
